Showing 301-310 of 1362 results for "".
Neuro-Oncology Outlook: Advancements in Targeted Molecular Therapy for Low-Grade Gliomas—Challenging the Treatment Paradigm
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuro-oncology-outlookbradvancements-in-targeted-molecular-therapy-for-low-grade-gliomas-challenging-the-treatment-paradigm/32121/Treatment with the IDH inhibitor vorasidenib increased median progression-free survival and time to next intervention in individuals with grade 2 gliomas under surveillance after surgical resection.Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.Transthyretin Familal Amyloid Neuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/transthyretin-familal-amyloid-neuropathy/31688/Early detection can lead to earlier interventions that can slow disease progression significantly- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31423/In July 2005, Practical Neurology highlighted the controversial remarks made by actor Tom Cruise regarding the field of psychiatry, reflecting broader implications for mental health advocacy and public perception. Cruise’s outspoken criticism emerged shortly after a public dispute with Brooke Shield
Frontotemporal Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/frontotemporal-dementias/31537/Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.The Whole Physician: Ten Action Items to Combat Peer-to-Peer and Institutional Racial Bias in Medicine
https://practicalneurology.com/columns/practice-management/the-whole-physician-ten-action-items-to-combat-peer-to-peer-and-institutional-racial-bias-in-medicine/32106/Biases that exist in medicine can be remedied with actions tailored to the individual, specific groups, and society at large.An Overview of Neurologic Complications of HIV and Opportunistic Infections
https://practicalneurology.com/diseases-diagnoses/imaging-testing/an-overview-of-neurologic-complications-of-hiv-and-opportunistic-infections/32154/Despite advances in treatment, neurologic complications remain prevalent in people with HIV infection.Neuromuscular Medicine & COVID-19
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-medicine-covid-19/31744/A myriad of neuromuscular complications have been associated with COVID-19 and individuals with underlying neuromuscular conditions have been affected as well.Direct Oral Anticoagulants for Secondary Stroke Prevention
https://practicalneurology.com/diseases-diagnoses/stroke/direct-oral-anticoagulants-for-secondary-stroke-prevention/30146/Optimal secondary stroke prevention includes reducing modifiable risk factors and providing anticoagulation for specific indications.